New Prospective Cohort Study Reporting the Efficacy of Arrow⢠Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
WAYNE, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today...
Truemed and ThrivePass Partner to Expand Access to Healthcare Through HSA/FSA Dollars